Shanghai Pulse Medical Technology, Inc.has raised more than $100 million in a series C funding round led by GL Ventures, Royal Philips, Goldman Sachs Asset Management and Boyu Capital. The funding will be used to accelerate the R&D, clinical trials and commercialization of its products.
About GL Ventures
GL Ventures focuses on early-stage innovative companies in healthcare, business services, broad consumption and industrials. The GL Ventures team is passionate about partnering with visionary entrepreneurs to create industry leaders that stand the test of time. GL Ventures is the venture capital arm of Hillhouse Group, and we have been investing with innovators across the world since 2005.